Advances in stem-cell–generated transplantation therapy for Parkinson's disease

Bibliography

• Trinh J, Farrer M. Advances in the genetics of Parkinson disease. Nat Rev Neurol 2013;9:445-54
   PubMed Web of Science ®Google Scholar
• Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-43
   PubMed Web of Science ®Google Scholar
• Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-53
   PubMed Web of Science ®Google Scholar
• Langston JW. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 2006;59:591-6
   PubMed Web of Science ®Google Scholar
• Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-44
   PubMed Web of Science ®Google Scholar
• Deleidi M, Cooper O, Hargus G, et al. Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons. PLoS One 2011;6:e19926
   PubMedGoogle Scholar
• Bergmann O, Liebl J, Bernard S, et al. The age of olfactory bulb neurons in humans. Neuron 2012;74:634-9
   PubMed Web of Science ®Google Scholar
• Bhardwaj RD, Curtis MA, Spalding KL, et al. Neocortical neurogenesis in humans is restricted to development. Proc Natl Acad Sci USA 2006;103:12564-8
   PubMed Web of Science ®Google Scholar
• Spalding KL, Bhardwaj RD, Buchholz BA, et al. Retrospective birth dating of cells in humans. Cell 2005;122:133-43
   PubMed Web of Science ®Google Scholar
• Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation into a Parkinson rat model. Proc Natl Acad Sci USA 2002;99:2344-9
   PubMed Web of Science ®Google Scholar
• Kriks S, Shim JW, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011;480:547-51
   PubMed Web of Science ®Google Scholar
• Kirkeby A, Grealish S, Wolf DA, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep 2012;1:703-14
   PubMed Web of Science ®Google Scholar
• Ma Y, Tang C, Chaly T, et al. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 2010;51:7-15
   PubMed Web of Science ®Google Scholar
• Isacson O, Deacon T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci 1997;20:477-82
   PubMed Web of Science ®Google Scholar
• Isacson O, Deacon TW. Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 1996;75:827-37
   PubMed Web of Science ®Google Scholar
• Cooper O, Hargus G, Deleidi M, et al. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 2010;45:258-66
   PubMed Web of Science ®Google Scholar
• Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010;107:15921-6
   PubMed Web of Science ®Google Scholar
• Sundberg M, Bogetofte H, Lawson T, et al. Improved cell therapy protocols for Parkinson’s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells 2013;31:1548-62
   PubMed Web of Science ®Google Scholar
• Redmond DE Jr, Vinuela A, Kordower JH, et al. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiol Dis 2008;29:103-16
   PubMed Web of Science ®Google Scholar
• Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-19
   PubMed Web of Science ®Google Scholar
• Mendez I, Vinuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 2008;14:507-9
   PubMed Web of Science ®Google Scholar
• Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 1999;56:179-87
   PubMed Web of Science ®Google Scholar
• Politis M, Wu K, Loane C, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010;2:38ra46
   PubMed Web of Science ®Google Scholar
• Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-14
   PubMed Web of Science ®Google Scholar
• Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002;5:627-8
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7
   PubMed Web of Science ®Google Scholar
• Reubinoff BE, Pera MF, Fong CY, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404
   PubMed Web of Science ®Google Scholar
• Mallon BS, Park KY, Chen KG, et al. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 2006;38:1063-75
   PubMed Web of Science ®Google Scholar
• Buzzard JJ, Gough NM, Crook JM, et al. Karyotype of human ES cells during extended culture. Nat Biotechnol 2004;22:381-2; author reply 382
   PubMed Web of Science ®Google Scholar
• Xi J, Liu Y, Liu H, et al. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012;30:1655-63
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-6
   PubMed Web of Science ®Google Scholar
• Ban H, Nishishita N, Fusaki N, et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 2011;108:14234-9
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science 2008;322:945-9
   PubMed Web of Science ®Google Scholar
• Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008;322:949-53
   PubMed Web of Science ®Google Scholar
• Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-70
   PubMed Web of Science ®Google Scholar
• Okita K, Matsumura Y, Sato Y, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409-12
   PubMed Web of Science ®Google Scholar
• Efe JA, Ding S. The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci 2011;366:2208-21
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-4
   PubMed Web of Science ®Google Scholar
• Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-77
   PubMed Web of Science ®Google Scholar
• Imaizumi Y, Okada Y, Akamatsu W, et al. Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 2012;5:35
   PubMed Web of Science ®Google Scholar
• Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. EMBO Mol Med 2012;4:380-95
   PubMed Web of Science ®Google Scholar
• Devine MJ, Ryten M, Vodicka P, et al. Parkinson's disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat Commun 2011;2:440
   PubMed Web of Science ®Google Scholar
• Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 2012;4:141ra190
   Web of Science ®Google Scholar
• Ono Y, Nakatani T, Sakamoto Y, et al. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 2007;134:3213-25
   PubMed Web of Science ®Google Scholar
• Fasano CA, Chambers SM, Lee G, et al. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 2010;6:336-47
   PubMed Web of Science ®Google Scholar
• Chambers SM, Fasano CA, Papapetrou EP, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009;27:275-80
   PubMed Web of Science ®Google Scholar
• Castelo-Branco G, Rawal N, Arenas E. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 2004;117:5731-7
   PubMedGoogle Scholar
• Ferri AL, Lin W, Mavromatakis YE, et al. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 2007;134:2761-9
   PubMed Web of Science ®Google Scholar
• Nakatani T, Kumai M, Mizuhara E, et al. Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon. Dev Biol 2010;339:101-13
   PubMed Web of Science ®Google Scholar
• Saucedo-Cardenas O, Quintana-Hau JD, Le WD, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci USA 1998;95:4013-18
   PubMed Web of Science ®Google Scholar
• Peng C, Aron L, Klein R, et al. Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons. J Neurosci 2011;31:12802-15
   PubMed Web of Science ®Google Scholar
• Thompson L, Barraud P, Andersson E, et al. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J Neurosci 2005;25:6467-77
   PubMed Web of Science ®Google Scholar
• Mendez I, Sanchez-Pernaute R, Cooper O, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;128:1498-510
   PubMed Web of Science ®Google Scholar
• Ganat YM, Calder EL, Kriks S, et al. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest 2012;122:2928-39
   PubMed Web of Science ®Google Scholar
• Sonntag KC, Pruszak J, Yoshizaki T, et al. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007;25:411-18
   PubMed Web of Science ®Google Scholar
• Doi D, Morizane A, Kikuchi T, et al. Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells 2012;30:935-45
   PubMed Web of Science ®Google Scholar
• Pruszak J, Ludwig W, Blak A, et al. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 2009;27:2928-40
   PubMed Web of Science ®Google Scholar
• Sundberg M, Jansson L, Ketolainen J, et al. CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res 2009;2:113-24
   PubMed Web of Science ®Google Scholar
• Pruszak J, Sonntag KC, Aung MH, et al. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 2007;25:2257-68
   PubMed Web of Science ®Google Scholar
• Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009;27:1050-6
   PubMed Web of Science ®Google Scholar
• Politis M, Oertel WH, Wu K, et al. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov Disord 2011;26:1997-2003
   PubMed Web of Science ®Google Scholar
• Hedlund E, Pruszak J, Lardaro T, et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008;26:1526-36
   PubMed Web of Science ®Google Scholar
• Ni HT, Hu S, Sheng WS, et al. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res 2004;152:159-69
   PubMedGoogle Scholar
• Sundberg M, Andersson PH, Akesson E, et al. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Cell Transplant 2011;20:177-91
   PubMed Web of Science ®Google Scholar
• Yuan SH, Martin J, Elia J, et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 2011;6:e17540
   PubMed Web of Science ®Google Scholar
• Sundberg M, Skottman H, Suuronen R, et al. Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium. Stem Cell Res 2010;5:91-103
   PubMed Web of Science ®Google Scholar
• Sundberg M, Hyysalo A, Skottman H, et al. A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production. Regen Med 2011;6:449-60
   PubMed Web of Science ®Google Scholar
• Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-80
   PubMed Web of Science ®Google Scholar
• Kolata G. Monkey model of Parkinson's disease. Science 1983;220:705
   PubMed Web of Science ®Google Scholar
• Saiki H, Hayashi T, Takahashi R, et al. Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease. J Neurosci Methods 2010;190:198-204
   PubMed Web of Science ®Google Scholar
• Decamp E, Schneider JS. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys. Eur J Neurosci 2006;24:2098-104
   PubMed Web of Science ®Google Scholar
• Doudet D, Gross C, Lebrun-Grandie P, et al. MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study. Brain Res 1985;335:194-9
   PubMed Web of Science ®Google Scholar
• Bezard E, Imbert C, Deloire X, et al. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey. Brain Res 1997;766:107-12
   PubMed Web of Science ®Google Scholar
• Kortekaas R, Eshuis SA, Andringa G, et al. Motor behavior correlates with striatal [(1)(8)F]-DOPA uptake in MPTP-lesioned primates. Neurochem Int 2013;62:349-53
   PubMed Web of Science ®Google Scholar
• Blesa J, Juri C, Collantes M, et al. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiol Dis 2010;38:456-63
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Albin RL, Koeppe RA, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 2006;26:1198-212
   PubMed Web of Science ®Google Scholar
• Emborg ME, Zhang Z, Joers V, et al. Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant 2013;22:831-8
   PubMed Web of Science ®Google Scholar
• Cicchetti F, Fodor W, Deacon TW, et al. Immune parameters relevant to neural xenograft survival in the primate brain. Xenotransplantation 2003;10:41-9
   PubMed Web of Science ®Google Scholar
• Deleidi M, Hargus G, Hallett P, et al. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Stem Cells 2011;29:1052-63
   PubMed Web of Science ®Google Scholar
• Emborg ME, Liu Y, Xi J, et al. Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep 2013;3:646-50
   PubMed Web of Science ®Google Scholar
• Hallett P, Deleidi M, Astradsson A, et al. Long-term function and survival of Cynomolgus monkey iPS cell-derived dopamine neurons following autologous transplantation in a non-human primate model of Parkinson's disease. Society for Neuroscience Annual Meeting 2013; San Diego, CA, USA; 2013
   Google Scholar
• Ahrlund-Richter L, De Luca M, Marshak DR, et al. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009;4:20-6
   PubMed Web of Science ®Google Scholar
• Opelz G, Wujciak T, Dohler B, et al. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999;1:334-42
   PubMedGoogle Scholar
• Taylor CJ, Bolton EM, Bradley JA. Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci 2011;366:2312-22
   PubMed Web of Science ®Google Scholar
• Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002;99:9864-9
   PubMed Web of Science ®Google Scholar
• Taylor CJ, Bolton EM, Pocock S, et al. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-25
   PubMed Web of Science ®Google Scholar
• Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-90
   PubMed Web of Science ®Google Scholar
• Okano H, Nakamura M, Yoshida K, et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 2013;112:523-33
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-15
   PubMed Web of Science ®Google Scholar
• Sanders LH, Laganiere J, Cooper O, et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol Dis 2013;62C:381-6
   Google Scholar
• Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-16
   PubMed Web of Science ®Google Scholar
• Martin MJ, Muotri A, Gage F, et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005;11:228-32
   PubMed Web of Science ®Google Scholar
• Heiskanen A, Satomaa T, Tiitinen S, et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 2007;25:197-202
   PubMed Web of Science ®Google Scholar
• Rajala K, Lindroos B, Hussein SM, et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 2010;5:e10246
   PubMed Web of Science ®Google Scholar
• International Stem Cell Initiative C, Akopian V, Andrews PW, et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim 2010;46:247-58
   PubMed Web of Science ®Google Scholar
• Heng BC, Li J, Chen AK, et al. Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev 2012;21:1701-15
   PubMed Web of Science ®Google Scholar
• Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011;8:424-9
   PubMed Web of Science ®Google Scholar
• Tannenbaum SE, Turetsky TT, Singer O, et al. Derivation of xeno-free and GMP-grade human embryonic stem cells – platforms for future clinical applications. PLoS One 2012;7:e35325
   PubMedGoogle Scholar
• Crook JM, Peura TT, Kravets L, et al. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007;1:490-4
   PubMed Web of Science ®Google Scholar
• Stephenson E, Jacquet L, Miere C, et al. Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc 2012;7:1366-81
   PubMed Web of Science ®Google Scholar
• Ilic D, Stephenson E, Wood V, et al. Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy 2012;14:122-8
   PubMed Web of Science ®Google Scholar
• Kuleshova LL, Tan FC, Magalhaes R, et al. Effective cryopreservation of neural stem or progenitor cells without serum or proteins by vitrification. Cell Transplant 2009;18:135-44
   PubMed Web of Science ®Google Scholar
• Morizane A DD, Kikuchi T, Okita K, et al. Direct comparison of autologous and allogeneic transplantation of iPSC- derived neural cells in the brain of a nonhuman primate. Stem Cell Reports 2013;1:283-92
   Google Scholar